Search form
Search
Login
Subscribe
Home
Country Intelligence
Industry Directory
Offsets / IC
Tenders
Australia
(13/week)
Haiti
(0/week)
Guyana
(0/week)
Honduras
(0/week)
Guatemala
(0/week)
View all
(13/week)
News
United States
(421/week)
Manufacturing
(319/week)
Technology
(320/week)
Energy
(213/week)
Other Manufacturing
(264/week)
Events
About us
Who we are
Our People
Partners
Contact us
LinkedIn
Login
Twitter
Register
Home
News
Multiple myeloma
Feb 12, 2019
U.S. FDA Approves DARZALEX® (daratumumab) Split-Dosing Regimen
Jan 29, 2019
Perlmutter Cancer Center Receives Anonymous $75 Million Gift To Establish New Center for Blood Cancers
Jan 29, 2019
Actinium Pharmaceuticals to Host Key Opinion Leader Breakfast on Targeted Conditioning for Bone Marrow Transplant and CAR-T on February 7th
Jan 24, 2019
The Multiple Myeloma Research Foundation (MMRF) Grows Leadership Team to Accelerate Precision Medicine and Cures
Jan 08, 2019
Cellular Biomedicine Group Initiates Patient Recruitment for Clinical Trial in B Cell Maturation Antigen (Anti-BCMA) Chimeric Antigen Receptor T-Cell (CAR-T) Therapy Targeting Multiple Myeloma (MM)
Dec 11, 2018
World-first Approval For Multiple Myeloma Drug APLIDIN(R)
Dec 04, 2018
New DARZALEX® (daratumumab) Phase 3 Study Shows Efficacy and Safety Data of Anti-CD38 Monoclonal Antibody in Patients with Newly Diagnosed Multiple Myeloma
Dec 04, 2018
CARsgen Presents Preliminary Results of CAR-BCMA T Cell Therapy at ASH 2018
Dec 03, 2018
CASI Pharmaceuticals Announces China Market Approval Of Melphalan Hydrochloride For Injection (Trademark: EVOMELA®)
Dec 03, 2018
Updated Data from Phase 1/2 Open-Label Study of BCMA-Directed CAR-T Cell Therapy LCAR-B38M Show Tolerable Safety Profile, High Overall Response and MRD Negative Rate in Treatment of Patients with Advanced Relapsed or Refractory Multiple Myeloma
Dec 03, 2018
Amgen Announces First-In-Human Data Evaluating Investigational Novel BiTE® Immunotherapies AMG 420 And AMG 330 At ASH 2018
Dec 02, 2018
Oncopeptides Presents First Interim Data From the Ongoing Combination Trial ANCHOR With Melflufen at the 60th American Society of Hematology Meeting
Dec 01, 2018
DARZALEX® (daratumumab) Combination Regimens Show Positive Results for Newly Diagnosed and Relapsed Patients with Multiple Myeloma
Dec 01, 2018
The MMRF CoMMpass Study Drives New Discoveries in Multiple Myeloma
Nov 29, 2018
The Multiple Myeloma Research Foundation (MMRF) Launches MyDRUG -- First-ever Platform Clinical Trial in Multiple Myeloma
Nov 27, 2018
Single-Cell Genomic Analysis of Blood Cancers to be Highlighted at American Society of Hematology Meeting
Nov 06, 2018
OWC Pharmaceutical Research Corp. to Meet With Investors, Researchers and Business Partners at 2018 MJBizCon; Revealing the Testing of Novel Formulation for Multiple Myeloma Therapy
Nov 01, 2018
Oncopeptides to Present Updated Data From the Two Ongoing Trials ANCHOR and HORIZON in Patients with RRMM at ASH in December 2018
Oct 31, 2018
In Multiple Myeloma, Janssen's Darzalex Posted Significant Gains Over the Past Six Months, but May Face an Increasingly Restrictive Payer Environment
Oct 25, 2018
The Myeloma Crowd(TM) Launches HealthTree® Aimed at Accelerating a Cure for Multiple Myeloma
‹‹
Page 6
››
Latest News
Mar 29, 2024
Universal Display Corporation to Deliver Keynote Address and Sponsor ICDT 2024
Mar 29, 2024
Cepton, Inc. Reports Fourth Quarter and Full Year 2023 Results
Mar 29, 2024
Ascent Industries Reports Fourth Quarter and Full Year 2023 Results
Mar 29, 2024
Surf Air Mobility Reports Financial Results for Fourth Quarter and Full Year Ended December 31, 2023
Mar 29, 2024
Planet Reports Financial Results for Fourth Quarter and Full Fiscal Year 2024
Mar 29, 2024
Fastenal Releases 2024 Environmental, Social, and Governance (ESG) Report
Mar 29, 2024
Danimer Scientific Announces Fourth Quarter and Full Year 2023 Results
Mar 29, 2024
CVD Equipment Corporation Reports Fourth Quarter and Fiscal Year 2023 Financial Results
View all News
Agenda
17
June
France
Parc des Expositions de Paris Nord Villepinte ZAC Paris Nord 2, 93420 Villepinte – France (Halls 5a – 5b – 6)
Eurosatory 2024, 17 - 21 June 2024, Parc des Expositions de Paris Nord Villepinte ZAC Paris Nord 2, 93420 Villepinte – France (Halls 5a – 5b – 6)
Eurosatory 2024 There can be no sustainable world without peace and security. Founded in 1967, the exhibition...
21
May
Paris Marriott Rive Gauche & Conference Center
Future Artillery, 21-23 May 2024, Paris Marriott Rive Gauche & Conference Center, France
DELIVERING FIRES IN THE MULTI-DOMAIN BATTLESPACE As artillery reasserts itself as the ‘King of Battlefield’ in the wake...
21
May
United Arab Emirates
ADNEC (Abu Dhabi National Exhibition Centre), Abu Dhabi, Al Khaleej Al Arabi St - Al Rawdah - Al Ma'arid - Abu Dhabi, UAE
ISNR Abu Dhabi 2024, 21-23 May 2024, ADNEC (Abu Dhabi National Exhibition Centre), Abu Dhabi, Al Khaleej Al Arabi St - Al Rawdah - Al Ma'arid - Abu Dhabi, UAE
ISNR ACCELERATING TRANSFORMATION IN THE NATIONAL SECURITY ECOSYSTEM ISNR Abu Dhabi is the region’s most trusted...
View All Events